This information is only accessible for healthcare professionals seeking more information on Reagila®(cariprazine) for the treatment of schizophrenia in adult patients. Please register here for further clinical and practical information.
- Home
- Over Reagila
- Werkingsmechanisme
Werkingsmechanisme
- Klinische data
Klinische data
- REAGILA in Patients with Acute Exacerbation of Schizophrenia
- REAGILA in The Long-Term Treatment of Schizophrenia
- REAGILA Controls Negative Symptoms in Schizophrenia
- Controlling Everyday Functioning with REAGILA®
- REAGILA’s Effects on Primary and Secondary Negative Symptoms: Pseudospecificity
- The Safety and Tolerability Profile of REAGILA
- The Management of Akathisia
- Cariprazine and Weight Gain
-
- Reagila Voorschrijven
- Educatie & events
- Aan te vragen
